Kane Biotech Inc Ord (KNBIF) Q3 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and thank you for standing by. Welcome to Kean Biotech's third quarter 2024 earnings conference call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be open to questions. If you have a question, please press star then 11 on your touchtone phone. If you would like to withdraw your question, please press star 11 again. This conference is being recorded today, December 3rd, 2024. I would now like to turn the conference call over to Ray Dupuy. Kane Biotech's Chief Financial Officer, please go ahead. Thank you, operator. Good afternoon and welcome everyone to Kane Biotech's third quarter 2024 earnings conference call. We are delighted to have you join us today. This call will cover Kane's financial and operating results along with the discussion of some of our recent highlights and goals for the remainder of 2024 and beyond. Following our prepared remarks, we will open the conference call to a question and answer session. Our call today will be led by CAEN's Chief Executive Officer, Mark Edwards. Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call contain certain forward-looking information and statements within the meanings of security law which may not be based on historical fact, including, without limitation, statements containing the words believes, should, may, plan, will, estimate, predict, continue, anticipates potential, intends, expects or other similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or...